Emerging relations between infectious diseases and coronary artery disease and atherosclerosis

CMAJ. Canadian Medical Association Journal

Volumn 163, Issue 1, 2000, Pages 49-56

  Fong, Ignatius W ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CAUSE OF DEATH; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION; PERIODONTAL DISEASE; REVIEW; RISK FACTOR;

EID: 0034636758     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. 1. Von Rokitansky CA. Manual of pathological anatomy [translated by Day GI]. vol 4. London: The Sydenham Society; 1852. p. 201-8.
2. 2. Virchow R. Gesammelte abhandlungen zur wissen-schaftilichen medicin: phlogose ung thrombose in Yefussystem. Berlin: Meidinger Sohn and Co.; 1856. p. 458-63.
3. 3. Ross R. Mechanisms of disease: atherosclerosis - an inflammatory disease [review]. N Engl J Med 1999;340:115-26.
4. 4. Ridker PM. Evaluating novel cardiovascular risk factors: Can we better predict heart attacks? Ann Intern Med 1999;130:933-7.
5. 5. Grunfeld C, Fiengold KR. Regulation of lipid metabolism by cytokines during host defense. Nutrition 1996;12(Suppl):S24-6.
6. 6. Neito FJ. Infection and atherosclerosis: new clues from an old hypothesis. Am J Epidemiol 1998;148:937-47.
7. 7. Osler W, editor. Diseases of the arteries. In: Modern medicine: its theory and practice. Philadelphia: Lea & Febiger; 1908. p. 426-47.
8. 8. Gibbon RV. Germs, Dr. Billings, and the theory of focal infection. Clin Infect Dis 1998;27:627-33.
9. 9. Fabricant CG, Knook L, Gillespie JH. Virus-induced cholesterol crystals. Science 1973;181:566-7.
10. 10. Saikku P, Matilla K, Nieminen MS, Leinonen M, Ekman MR. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
11. 11. Danesh J, Collins R, Petro R. Chronic infections and coronary heart disease: Is there a link? Lancet 1997;350:430-6.
12. 12. Gratton MT. Accelerated graft atherosclerosis following cardiac transplantation: clinical perspectives. Clin Cardiol 1991;141(Suppl 2):16-20.
13. 13. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, et al. Association between prior cytomegalovirus infection and risk of restenosis after coronary atherectomy. N Engl J Med 1996;335:624-30.
14. 14. Epstein SE, Speir E, Zhou YF, Guetta E, Leon M, Finkel T. The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet 1996;348:13-7.
15. 15. Adler SP, Hur JK, Wang JB, Vetrovec GW. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis 1998;177:209-12.
16. 16. Rothenbacher D, Hoffmeister A, Bode G, Wanner P, Koenig W, Brenner H. Cytomegalovirus infection and coronary heart disease: results of a German case-control study. J Infect Dis 1999;179:690-2.
17. 17. Ridker PM, Hennekens CH, Stampfer MJ, Wang F. Prospective study of herpes simplex virus, cytomegalovirus and the risk of future myocardial infarction and stroke. Circulation 1998;98:2796-9.
18. 18. Sorlie PD, Adam K, Melnick SL, Folson A, Skelton T, Chambless LE, et al. Cytomegalovirus, herpes virus and carotid atherosclerosis: the ARIC study. J Med Virol 1994;42:33-7.
19. 19. Gyorkey F, Melnick JL, Guinn GA, Gyorkey P, DeBakey ME. Herpes viridae in the endothelial and smooth muscle cells of the proximal aorta of atherosclerotic patients. Exp Mol Pathol 1984;64:359-62.
20. 20. Benditt EP, Barrett T, McDougall JK. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 1983;80:6386-9.
21. 21. Melnick JL, Petrie BL, Dreesman GR, Burek J, McCollum CH, DeBakey ME. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983;2:644-7.
22. 22. Hajjar DP, Pomerantz KB, Falcone DJ, Weksler BB, Grant AJ. Herpes simplex virus infection in human arterial cells: implications in atherosclerosis. J Clin Invest 1987;80:1317-21.
23. 25. Yamashinoya HM, Ghosh L, Yang R, Robertson AL. Herpes viridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 1988;130:71-9.
24. 24. Hendricks MGR, Salimess MMM, Vanboven CPA, Bruggeman CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990;136:23-8.
25. 25. Melnick JL, Hu C, Burek J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 1994;42:170-4.
26. 26. Speir E, Yu ZX, Ferrans VJ. Infectious agents in coronary artery disease: viral infection, aspirin and gene expression in human coronary smooth muscle cells. Rev Port Cardiol 1998;17(Suppl 2):II33-9.
27. 27. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994;265:391-4.
28. 28. Jacob HS, Viscer M, Kay NS, Goodman JL, Moldow CF, Vercellotti GM. Herpes virus infection of endothelium: new insights into atherosclerosis. Trans Am Clin Climatol Assoc 1992;103:95-104.
29. 29. Minick CR, Fabricant CG, Fabricant J, Litrenta MM. Atheroarteriosclerosis induced by infection with a herpesvirus. Am J Pathol 1979;96:673-706.
30. 30. Span AHM, Gravis G, Bosman F, Van Boven CPA, Bruggernan CA. Cytomegalovirus infection induces vascular injury in the rat. Atherosclerosis 1992;93:41-52.
31. 31. Lemström KB, Bruning JH, Bruggerman CA, Lautenschlager IT, Häyry P. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest 1993;92:549-58.
32. 32. Lemström K, Sihvola R, Bruggerman C, Häyry P, Koskinen P. Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat. Circulation 1997;95:2614-6.
33. 33. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Invest Dis 1992;15:757-61.
34. 34. Strong JP, Malcolm GT, McMahon CA, Tracey RE, Newman WP III, Herderick EE, et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 1999;281:727-35.
35. 35. Ossewaarde JM, Feskers EJ, DeVries A, Vallinga CE, Kromhout D. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 1998;120:93-9.
36. 36. Maas M, Gieffers J. Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile. J Infect 1997;35:171-6.
37. 37. Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstand J. Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke 1999;30:299-305.
38. 38. Miyashita N, Toyota E, Sawayama T, Matsumoto A, Mikami Y, Kawai N, et al. Association of chronic infection of Chlamydia pneumoniae and coronary heart disease in the Japanese. Intern Med 1998;37:913-6.
39. 39. Thomas GN, Scheel O, Koehler AP, Bassett DC, Cheng AF. Respiratory chlamydial infections in a Hong Kong teaching hospital and association with coronary heart disease. Scand J Infect Dis 1997;104(Suppl):30-3.
40. 40. Cook PJ, Honeybourne D, Lip GY, Beavers DG, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 1998;29:404-10.
41. 41. Strachan DP, Carrington D, Mendall MA, Ballam L, Morris J, Butland BK, et al. Relationship of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly Prospective Heart Study. BMJ 1999;318:1035-40.
42. 42. Ridker PM, Kundsin RB, Stampfer MJ, Poulin S, Hennekens CH. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infraction. Circulation 1999;99:1161-4.
43. 43. Laurila A, Blvigu A, Nayha S, Hossi J, Leinonen M, Saikku P. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:2910-3.
44. 44. Grayston JT, Campbell LA. The role of Chlamydia pneumoniae in atherosclerosis. Clin Infect Dis 1999;28:993-4.
45. 45. Weiss SM, Roblin PM, Gaydos CA, Cummings P, Patton DL, Schulhoff N, et al. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 1996;173:957-62.
46. 46. Campbell LA, O'Brien ER, Cappuccio A, Kuo CC, Wang SP, Stewart D, et al. Detection of Chlamydia pneumoniae (TWAR) in human atherectomy tissues. J Infect Dis 1995;172:585-8.
47. 47. Paterson DL, Hall J, Rasmussen SJ, Timms P. Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. Pathology 1998;30:169-72.
48. 48. Jackson LA, Campbell LA, Schmidt RA, Kuo CC, Cappuccio AL, Lee MJ, et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol 1997;150:1785-90.
49. 49. Jantos CA, Nesseler A, Waas W, Baumgartner W, Tillmans H, Haberbosch W. Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease. Clin Infect Dis 1999;28:988-92.
50. 50. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997;96:2144-8.
51. 51. Jackson LA, Campbell LA, Kuo CC, Rodriguez DL, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997;176:292-5.
52. 52. Ramirez JA. Chlamydia pneumoniae/atherosclerosis Study Group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 1996;125:979-82.
53. 53. Maas M, Battels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998;31:827-32.
54. 54. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cell. Infect Immun 1996;64:1414-20.
55. 55. Coombes BK, Mahony JB. Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s). Infect Immun 1999;67:2909-15.
56. 56. Kalayoglu MV, Byrne GI. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun 1998;66:5067-72.
57. 57. Kol A, Sukhova GK, Lichtman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998;98:300-7.
58. 58. Kol A, Boucier T, Lichtman AH, Libby P. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999;103:571-7.
59. 59. Kalayoglu MV, Hoerneman B, La Verda D, Morrison SG, Morrison RP, Byrne GI. Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis 1999;180:780-90.
60. 60. Fong IW, Chiu B, Viira E, Fong MW, Jang D, Mahony JB. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 1997;35:48-52.
61. 61. Laitinen K, Laurila A, Pyhala L, Leinonen M, Saikku P. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun 1997;65:4832-5.
62. 62. Fong IW, Chiu B, Viira E, Jang D, Mahony JB. De novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model. Infect Immun 1999;67:6048-55.
63. 63. Muhlestein JB, Anderson JL, Hammond EH, Zhao L, Trehan S, Schwobe EP, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97:633-6.
64. 64. Moazed TC, Kuo CC, Grayston JT, Campbell LA. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 1997;175:883-90.
65. 65. Hu H, Pierce GN, Zhang G. Arherogenic effects of Chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 1999;103:747-53.
66. 66. Moazed TC, Campbell LA, Rosenfield ME, Grayston JT, Kuo CC. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in alipoprotein E-deficient mice. J Infect Dis 1999;180:238-41.
67. 67. Meier CR, Derby LE, Jick SS, Vasilakis C, Jick H. Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA 1999;287:427-31.
68. 68. Jackson LA, Smith NL, Heckbert SR, Grayston JT, Siscovick DS, Psaty MB. Lack of association between first myocardial infarction and past use of erythromycin, tetracycline or doxycycline. Emerg Infect Dis 1999;5:281-4.
69. 69. Gurfinkel E, Bozovich G, Doroca A, Beck E, Mautner B, for the ROXIS Study Group. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. Lancet 1997;350:404-7.
70. 70. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of acute myocardial infarction. Circulation 1997;96:404-7.
71. 71. Gurfinkel C, Bozovich G, Beck E, Testa E, Livellara B, Mautner B. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wavc coronary syndromes. The final report of the ROXIS Study. Eur Heart J 1999;20:121-7.
72. 72. Anderson JL, Muhlestein JB, Carlquist J, Allen A, Trehan S, Nielson C, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. Circulation 1999;99:1540-7.
73. 73. Ossei-Gerning N, Moayyedi P, Smith S, Braunholtz D, Wilson JI, Axon AT, et al. Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res 1997;35:120-4.
74. 74. de Luis DA, Lahera M, Canton R, Boixeda D, San Roman AL, Aller R, et al. Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care 1998;21:1129-32.
75. 75. Markus HS, Mendall MA. Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry 1998;64:104-7.
76. 76. McDonagh TA, Woodward M, Morrison CE, McMurray JJ, Tunstall-Pedoe H, Lowe GD, et al. Helicobacter pylori infection and coronary heart disease in the Glascow MONICA population. Eur Heart J 1997;18:1257-60.
77. 77. Folsom AR, Neito FJ, Sorlie P, Chombless LE, Graham DY. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 1998;98:845-50.
78. 78. Khurshid A, Fenske T, Bajwa T, Bourgeois K, Vakil N. A prospective, controlled study of Helicobacter pylori seroprevalence in coronary artery disease. Am J Gastroenterol 1998;93:717-20.
79. 79. Blasi F, Denti F, Erba M, Cosentini R, Raccanelli R, Rinaldi A, et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic ancurysms. J Clin Microbiol 1996;34:2766-9.
80. 80. Danesh J, Koreth J, Youngman L, Collins R, Arnold J, Balarajan Y, et al. Is Helicobacter pylori a factor in coronary atherosclerosis? J Clin Microbiol 1999;37: 1651-1.
81. 81. Murray LJ, Bamford KB, O'Reilly DPJ, McCrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease and social class. Br Heart J 1995;74:497-501.
82. 82. Torgano G, Consentini R, Mandelli C, Perondi R, Blasi F, Bertinieri G, et al. Treatment of Helicobacter pylori and Chlamydia pneumonias infections decreases fibrinogen plasma levels in patients with ischemic heart disease. Circulation 1999;99:1555-9.
83. 83. Matilla KJ, Neiminen MS, Valtonen VV, Rasi VP, Kesaniemi YA, Syrjala SL, et al. Association between dental health and acute myocardial infarction. BMJ 1989;298:779-81.
84. 84. Loesche WJ, Schonk A, Terpenning MS, Chen YM, Kerr C, Domingirez BL. The relationship between dental disease and cerebrovascular accident in elderly United States veterans. Ann Periodontol 1998;3:161-74.
85. 85. Paurio K, Impivaara O, Tiekso J, Mäki J. Missing teeth and ischaemic heart disease in men aged 45-64 years. Eur Heart J 1993;14(Suppl K):54-6.
86. 86. Beck J, Garcia R, Heiss G, Vokonas PS, Offerbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996;67:1123-32.
87. 87. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. BMJ 1993;306:688-91.
88. 88. Seymour RA, Steele JG. Is there a link between periodontal disease and coronary heart disease? Br Dent J 1998;184:33-8.
89. 89. Joshipura KJ, Douglass CW, Willett WC. Possible explanations for the tooth loss and cardiovascular disease relationship. Ann Periodontol 1998;3:175-83.
90. 90. Lowe GDO, Kweider M, Murray GD, Kinase D, McGowan DA. Fibrinogen and dental disease - a coronary risk factor. In: Ernst E, Koenig W, Lowe GDO, Meade T, editors. Fibrinogen - a "new" cardiovascular risk factor. Oxford: Blackwell; 1992. p. 187-91.
91. 91. Matilla KJ, Rasi V, Nieminen M. Von Willebrand factor antigen and dental infections. Thromb Res 1989;56:325-91.
92. 92. Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun 1998;66:5337-43.
93. 93. Herzberg MC, MacFarlane GD, Gong K. The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis. Infect Immun 1992;60:4809-18.
94. 94. Imamura T, Potempa J, Tanase S, Travis J. Activation of blood coagulation factor X by anginase-specific cysteine proteinase (gingipain-Rs) from Porphyromonas gingivalis. J Biol Chem 1997;272:16062-7.
95. 95. Herzberg MC, Meyer MW. Dental plaque, platelets and cardiovascular disease. Ann Periodontol 1998;3:151-60.